NEOG - NEOGEN CORP
5.97
-0.020 -0.335%
Share volume: 5,078,085
Last Updated: 05-09-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$5.99
-0.02
0.00%
Summary score
52%
Profitability
44%
Dept financing
27%
Liquidity
60%
Performance
64%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 31-Dec-2013 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.6%
Return on assets
3.18%
Return on sales
17.76%
Return on invested capital
6.4%
Total debt ratio
11.02%
Debt ratio change over timeo
0%
Current Ratio
8.32%
Quick Ratio
6.27%
Cash Position Ratio
2%
Short-term ratios 31-Dec-2016 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
2.66%
Return on assets
3.12%
Return on sales
17.59%
Return on invested capital
6.43%
Total debt ratio
11.08%
Debt ratio change over timeo
0%
Current Ratio
8.3%
Quick Ratio
6.28%
Cash Position Ratio
1.78%
Last quarter ratios 31-Dec-2017
The data are presented for the financials results of the last quarter.
Return on equity
3.29%
Return on assets
3.1%
Return on sales
17.68%
Return on invested capital
8.42%
Total debt ratio
10.44%
Debt ratio change over time
0%
Current Ratio
8.96%
Quick Ratio
7.02%
Cash Position Ratio
1.7%
Performance ratios (change over 4 years) 31-Dec-2013 - 31-Dec-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NEOG | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 2.6% | -161.59% | 63.05% | -0.85% |
| Return on assets | 3.18% | 6.18% | 4.66% | 1.09% |
| Return on sales | 17.76% | 20.59% | 15.86% | 5.81% |
| Return on invested capital | 6.4% | -37.01% | 14.42% | -0.73% |
| Profitability | 47% | 50% | 88% | 11% |
| Total debt ratio | 11.02% | 102.87% | 130.65% | 52.36% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 20% | 25% | 10% |
| Current Ratio | 8.3% | 0.92% | 2.94% | 6.11% |
| Quick Ratio | 6.28% | 0.75% | 2.43% | 5.46% |
| Cash Position Ratio | 1.78% | 0.17% | 1.37% | 4.27% |
| Liquididy | 61% | 7% | 25% | 68% |
| Short-term ratios | NEOG | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 2.66% | -101.94% | 96.6% | -0.96% |
| Return on assets | 3.12% | 6.27% | 4.61% | 1.12% |
| Return on sales | 17.59% | 20.94% | 15.54% | 4.79% |
| Return on invested capital | 6.43% | -26.98% | 19.42% | -0.67% |
| Profitability | 42% | 50% | 87% | 10% |
| Total debt ratio | 11.08% | 104.01% | 123.68% | 53.85% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 21% | 25% | 11% |
| Current Ratio | 8.3% | 0.92% | 2.94% | 6.11% |
| Quick Ratio | 6.28% | 0.75% | 2.43% | 5.46% |
| Cash Position Ratio | 1.78% | 0.17% | 1.37% | 4.27% |
| Liquididy | 60% | 7% | 27% | 65% |
